Pfizer $43B Cancer Investment March 2023

Pfizer announced a $43 billion investment to advance its cancer treatment portfolio, including its proposed acquisition of Seagen. The presentation outlines Pfizer's strategic commitment to developing breakthrough oncology therapies and expanding its pipeline of cancer-fighting medicines to improve patient outcomes.